The effect of subcutaneous tumour implantation in a murine lung tumour model

European Journal of Cardio-thoracic Surgery

Volumn 21, Issue 4, 2002, Pages 616-620

  John, L C H ^a,b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Biological; Immunotherapy; Lung neoplasms; Mice; Models; Surgery

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RECURRENCE; CANCER TRANSPLANTATION; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; LUNG CARCINOMA; LUNG RESECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECIPIENT; T LYMPHOCYTE; TUMOR CELL;

ANIMALS; CARCINOMA; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; LUNG; LUNG NEOPLASMS; MICE; MICE, INBRED A; NEOPLASM SEEDING; TIME FACTORS;

EID: 0036204814     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(02)00040-4     Document Type: Article

References (14)

1. Postoperative therapy for loco regional non-small cell lung cancer
2. Immunoregulation of carcinogenesis: past, present and future
3. Laparotomy enhances intraperitoneal tumour growth and abrogates the anti-tumour effects of interleukin-2 and lymphokine-activated killer cells
4. Accelerated growth of testicular cancer after cytoreductive surgery
5. Subcutaneously implanted tumour: a hypothesised novel approach to individualised immunotherapy for lung carcinoma
6. Proliferative lesions of the mouse lung: progression studies in strain A mice
7. The role of the alveolar type II cell in the development and progression of pulmonary tumours induced by NNK in the A/J mouse
8. Active specific immunotherapy with an autologous tumour cell vaccine in patients with resected non-small cell lung cancer
9. Adjuvant specific immunotherapy of resectable squamous cell lung carcinoma
10. A phase III randomised study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or non curative resection of primary lung carcinoma
11. A randomised trial of adoptive immunotherapy with tumour infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected non-small cell lung carcinoma
12. Changes in T lymphocyte subsets after elective surgery
13. Natural killer cell activity during premedication, anaesthesia and surgery
14. + T cells in cancer immunotherapy